First Allied Advisory Services’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
$1.51M Buy
14,849
+10,171
+217% +$878K 0.05% 360
2020
Q2
$407K Buy
4,678
+74
+2% +$5.91K 0.02% 716
2020
Q1
$267K Sell
4,604
-1,035
-18% -$84K 0.01% 811
2019
Q4
$518K Sell
5,639
-3,444
-38% -$303K 0.02% 700
2019
Q3
$820K Buy
9,083
+5,953
+190% +$678K 0.03% 523
2019
Q2
$369K Sell
3,130
-3,560
-53% -$359K 0.01% 798
2019
Q1
$582K Buy
6,690
+2,762
+70% +$235K 0.02% 626
2018
Q4
$249K Buy
3,928
+253
+7% +$17.4K 0.01% 863
2018
Q3
$289K Buy
+3,675
New +$240K 0.01% 920

Other funds holding EXAS

First Allied Advisory Services's EXAS Position: Q3 2020 in Review

First Allied Advisory Services increased its Exact Sciences (EXAS) stake by 217% in Q3 2020, buying an estimated $878K and bringing the position to 14,849 shares worth $1.51M. The position accounts for 0.05% of the portfolio, ranked #360.

First Allied Advisory Services first reported a position in EXAS in Q3 2018 and has held it in 9 quarters since. 516 funds tracked by Wall St. Rank hold EXAS as of Q3 2020.

  • First Allied Advisory Services held 14,849 shares of Exact Sciences worth $1.51M as of Q3 2020.
  • First Allied Advisory Services bought 10,171 Exact Sciences shares in Q3 2020, an estimated $878K.
  • Exact Sciences made up 0.05% of First Allied Advisory Services's portfolio in Q3 2020, its #360 holding.
  • First Allied Advisory Services first reported a position in Exact Sciences in Q3 2018 and has held it in 9 quarters since.
  • 516 funds tracked by Wall St. Rank held Exact Sciences as of Q3 2020.

Based on First Allied Advisory Services's 13F filing for Q3 2020, filed 13 Nov 2020.